Anatara Lifesciences is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. Our lead product Detach™ is a natural product that will help address global concerns around the overuse of antibiotics in animals and their feed that is contributing to the rise of so-called “super bugs” that make infectious diseases harder to treat. The Anatara team has a strong track record in biological science as well as building and growing international biotech companies.
Latest news All news
Anatara Lifesciences has released its Appendix 4C Interim Financial Report, for the 3rd quarter ended 31 March 2015, to the market today.
Please click here to view the ASX announcement.
Anatara has released its latest investor presentation to the Australian Securities Exchange.
Please click here to view the presentation.